Insider · CIK 0001526335

Underdown Brian J.

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001526335

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-19	VTGNVistagen Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$1.50	+$3,750	2,500
2021-03-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2020-12-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2020-04-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2019-10-21	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2019-05-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−500 sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+500 sh	—	—	500
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,250 sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,250 sh	—	—	6,250
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2018-08-05	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2018-02-02	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2017-09-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-04-26	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2016-11-09	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-06-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+2,500 sh	—	—	2,500
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+7,500 sh	—	—	7,500
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+2,500 sh	—	—	2,500
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+20K sh	—	—	20,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+50K sh	—	—	50,000
2015-09-02	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+50K sh	—	—	50,000
2015-06-17	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	16,500
2015-06-17	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2015-01-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	Director	AAward	+20K sh	—	—	20,000
2014-03-19	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockJ Other	Director	JOther	+50K sh	—	—	50,000
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+13.1K sh	—	—	13,131
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+43.2K sh	—	—	56,316
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+583K sh	—	—	639,085
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+570K sh	—	—	1,209,075
2014-02-12	ARGOS THERAPEUTICS INCP Purchase	Director	PPurchase	+40.5K sh	$8.00	+$324K	1,249,572
2014-02-12	ARGOS THERAPEUTICS INCSeries B Preferred StockC Conversion	Director	CConversion	−13.1K sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries C Preferred StockC Conversion	Director	CConversion	−43.2K sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries D Preferred StockC Conversion	Director	CConversion	−583K sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries E Preferred StockC Conversion	Director	CConversion	−570K sh	—	—	0
2013-12-20	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2013-12-20	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Mar 224
Underdown Brian J.0001415889-21-001609
SEC(opens sec.gov)
Jan 44
Underdown Brian J.0001415889-21-000012
SEC(opens sec.gov)
Apr 274
Underdown Brian J.0001415889-20-001062
SEC(opens sec.gov)
Oct 224
Underdown Brian J.0001415889-19-001209
SEC(opens sec.gov)
May 284
Underdown Brian J.0001415889-19-000593
SEC(opens sec.gov)
Aug 314
Underdown Brian J.0001415889-18-001316
SEC(opens sec.gov)
Aug 64
Underdown Brian J.0001415889-18-001228
SEC(opens sec.gov)
Feb 54
Underdown Brian J.0001415889-18-000182
SEC(opens sec.gov)

Companies

Address

C/O VISTAGEN THERAPEUTICS, INC. 384 OYSTER POINT BLVD., NO 8.

SOUTH SAN FRANCISCO, CA, 94080